Viorgon-13

Ovarian tissue bioregulator.

Composition: 1 ml of sterile solution contains; 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of the protein-peptide complex isolated from the ovarian tissue of young cows.

Physiological effect: Viorgon-13 is associated with its property to additionally activate cellular sources of female genital regeneration, maintain cell viability, as well as intercellular adhesive interactions.

Indications for use: Viorgon-13 is recommended for the normalization of the menstrual cycle, with ovarian dysfunction, inflammation of the appendages, infertility.

Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.

Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.

A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.

The interval between the various viorgons is at least 10 minutes.